TickerFactsScreenerDevelopers

Xenetic Biosciences, Inc. (XBIO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: $14.80M2012: $20.78M2013: $12.62M2014: $10.48M2015: $6.61M2016: $16.17M2017: $14.30M2018: $9.91M2019: $17.21M2020: $12.22M2021: $18.39M2022: $13.65M2023: $9.80M2024: $6.01M2025: $7.40M$7.40M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$7.40M+23.1%
2024$6.01M-38.7%
2023$9.80M-28.2%
2022$13.65M-25.8%
2021$18.39M+50.6%
2020$12.22M-29.0%
2019$17.21M+73.6%
2018$9.91M-30.7%
2017$14.30M-11.6%
2016$16.17M+144.7%
2015$6.61M-36.9%
2014$10.48M-16.9%
2013$12.62M-39.3%
2012$20.78M+40.4%
2011$14.80M—